{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:53:12Z","timestamp":1794538392850,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T00:00:00Z","timestamp":1690070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T00:00:00Z","timestamp":1690070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS089022"],"award-info":[{"award-number":["R01NS089022"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS100876"],"award-info":[{"award-number":["R01NS100876"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS129567"],"award-info":[{"award-number":["RF1NS129567"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32NS082168"],"award-info":[{"award-number":["T32NS082168"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG057933"],"award-info":[{"award-number":["RF1AG057933"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F30AG063446"],"award-info":[{"award-number":["F30AG063446"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Post-translational modifications to the carboxyl (C) terminus domain of \u03b1-synuclein can play an important role in promoting the pathologic aggregation of \u03b1-synuclein. Various cleavages that diminish this highly charged, proline-rich region can result in exposure of hydrophobic, aggregation-prone regions, thereby accelerating the aggregation kinetics of \u03b1-synuclein into misfolded, pathologic forms. C-terminally truncated forms of \u03b1-synuclein are abundant in human diseased brains compared to controls, suggesting a role in disease pathogenesis. Factors that alter the homeostatic proteolytic processing of \u03b1-synuclein may ultimately tip the balance towards a progressive disease state. Apolipoprotein E (APOE) has been implicated in the acceleration of cognitive impairment in patients with Lewy body diseases. The APOE4 isoform  has\u00a0been found to cause dysregulation in the endosomal\u2013lysosomal pathway, which could result in altered \u03b1-synuclein degradation as a potential mechanism for promoting its pathologic misfolding. Herein, we investigate the spatiotemporal accumulation of C-terminally truncated \u03b1-synuclein in a seeded and progressive mouse model of synucleinopathy. Furthermore, we study how this process is influenced in the context of mice that are altered to express either the human APOE3 or APOE4 isoforms. We found that specific C-terminal truncation of \u03b1-synuclein occurs at early stages of pathogenesis. We also found that proteolytic processing of this domain differs across various brain regions and is influenced by the presence of different human APOE isoforms. Our data demonstrate an early pathogenic role for C-terminally truncated \u03b1-synuclein, and highlight the influence of APOE isoforms in modulating its impact.<\/jats:p>","DOI":"10.1186\/s40478-023-01623-9","type":"journal-article","created":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T06:01:13Z","timestamp":1690092073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Carboxyl truncation of \u03b1-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of \u03b1-synuclein pathogenesis"],"prefix":"10.1186","volume":"11","author":[{"given":"Grace M.","family":"Lloyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Quintin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary A.","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly-Marie M.","family":"Gorion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brach M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Borchelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2992-4234","authenticated-orcid":false,"given":"Benoit I.","family":"Giasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,23]]},"reference":[{"key":"1623_CR1","unstructured":"Allen Institute for Brain Science (2004) Interactive Atlas viewer: Atlas viewer. In: Allen mouse brain atlas. Accessed 13 Mar 2023"},{"key":"1623_CR2","doi-asserted-by":"publisher","first-page":"9593","DOI":"10.1073\/pnas.1609291113","volume":"113","author":"F Bassil","year":"2016","unstructured":"Bassil F, Fernagut PO, Bezard E, Pruvost A, Leste-Lasserre T, Hoang QQ, Ringe D, Petsko GA, Meissner WG (2016) Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. Proc Natl Acad Sci U S A 113:9593\u20139598. https:\/\/doi.org\/10.1073\/pnas.1609291113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1623_CR3","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s12035-022-02851-1","volume":"59","author":"T Behl","year":"2022","unstructured":"Behl T, Kumar S, Althafar ZM, Sehgal A, Singh S, Sharma N, Badavath VN, Yadav S, Bhatia S, Al-Harrasi A, Almoshari Y, Almikhlafi MA, Bungau S (2022) Exploring the role of ubiquitin-proteasome system in Parkinson\u2019s disease. Mol Neurobiol 59:4257\u20134273. https:\/\/doi.org\/10.1007\/s12035-022-02851-1","journal-title":"Mol Neurobiol"},{"key":"1623_CR4","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","volume":"23","author":"J Bras","year":"2014","unstructured":"Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J (2014) Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet 23:6139\u20136146. https:\/\/doi.org\/10.1093\/hmg\/ddu334","journal-title":"Hum Mol Genet"},{"key":"1623_CR5","doi-asserted-by":"publisher","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","volume":"8","author":"J Burr\u00e9","year":"2018","unstructured":"Burr\u00e9 J, Sharma M, S\u00fcdhof TC (2018) Cell biology and pathophysiology of \u03b1-synuclein. Cold Spring Harb Perspect Med 8:a024091. https:\/\/doi.org\/10.1101\/cshperspect.a024091","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1623_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.nbd.2006.02.004","volume":"23","author":"L Chen","year":"2006","unstructured":"Chen L, Thiruchelvam MJ, Madura K, Richfield EK (2006) Proteasome dysfunction in aged human \u03b1-synuclein transgenic mice. Neurobiol Dis 23:120\u2013126. https:\/\/doi.org\/10.1016\/j.nbd.2006.02.004","journal-title":"Neurobiol Dis"},{"key":"1623_CR7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01949.x","volume":"86","author":"AS Crystal","year":"2003","unstructured":"Crystal AS, Giasson BI, Crowe A, Kung MP, Zhuang ZP, Trojanowski JQ, Lee VMY (2003) A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114. J Neurochem 86:1359\u20131368. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01949.x","journal-title":"J Neurochem"},{"key":"1623_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cell.2018.06.035","volume":"174","author":"TL Daigle","year":"2018","unstructured":"Daigle TL, Madisen L, Hage TA, Valley MT, Knoblich U, Larsen RS, Takeno MM, Huang L, Gu H, Larsen R, Mills M, Bosma-Moody A, Siverts LA, Walker M, Graybuck LT, Yao Z, Fong O, Nguyen TN, Garren E, Lenz GH, Chavarha M, Pendergraft J, Harrington J, Hirokawa KE, Harris JA, Nicovich PR, McGraw MJ, Ollerenshaw DR, Smith KA, Baker CA, Ting JT, Sunkin SM, Lecoq J, Lin MZ, Boyden ES, Murphy GJ, da Costa NM, Waters J, Li L, Tasic B, Zeng H (2018) A suite of transgenic driver and reporter mouse lines with enhanced brain-cell-type targeting and functionality. Cell 174:465-480.e22. https:\/\/doi.org\/10.1016\/j.cell.2018.06.035","journal-title":"Cell"},{"key":"1623_CR9","doi-asserted-by":"publisher","first-page":"eaay3069","DOI":"10.1126\/scitranslmed.aay3069","volume":"12","author":"AA Davis","year":"2020","unstructured":"Davis AA, Inman CE, Wargel ZM, Dube U, Freeberg BM, Galluppi A, Haines JN, Dhavale DD, Miller R, Choudhury FA, Sullivan PM, Cruchaga C, Perlmutter JS, Ulrich JD, Benitez BA, Kotzbauer PT, Holtzman DM (2020) APOE genotype regulates pathology and disease progression in synucleinopathy. Sci Transl Med 12:eaay3069. https:\/\/doi.org\/10.1126\/scitranslmed.aay3069","journal-title":"Sci Transl Med"},{"key":"1623_CR10","doi-asserted-by":"publisher","first-page":"e0184731","DOI":"10.1371\/journal.pone.0184731","volume":"12","author":"J-KS Dhillon","year":"2017","unstructured":"Dhillon J-KS, Riffe C, Moore BD, Ran Y, Chakrabarty P, Golde TE, Giasson BI (2017) A novel panel of \u03b1-synuclein antibodies reveal distinctive staining profiles in synucleinopathies. PLoS ONE 12:e0184731. https:\/\/doi.org\/10.1371\/journal.pone.0184731","journal-title":"PLoS ONE"},{"key":"1623_CR11","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN, van Gerpen JA, Uitti RJ, Wszolek ZK, Ertekin-Taner N, Knopman DS, Petersen RC, Graff-Radford NR, Boeve BF, Bu G, Ferman TJ, Ross OA (2018) APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91:e1182\u2013e1195. https:\/\/doi.org\/10.1212\/WNL.0000000000006212","journal-title":"Neurology"},{"key":"1623_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","volume":"86","author":"I Dikic","year":"2017","unstructured":"Dikic I (2017) Proteasomal and autophagic degradation systems. Annu Rev Biochem 86:193\u2013224. https:\/\/doi.org\/10.1146\/annurev-biochem-061516-044908","journal-title":"Annu Rev Biochem"},{"key":"1623_CR13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/jnen\/59.9.830","volume":"59","author":"JE Duda","year":"2000","unstructured":"Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, Hurtig HI, Stern MB, Gollomp SM, Grossman M, Lee VMY, Trojanowski JQ (2000) Immunohistochemical and biochemical studies demonstrate a distinct profile of \u03b1-Synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol 59:830\u2013841. https:\/\/doi.org\/10.1093\/jnen\/59.9.830","journal-title":"J Neuropathol Exp Neurol"},{"key":"1623_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nn2058","volume":"11","author":"G Gallardo","year":"2008","unstructured":"Gallardo G, Schl\u00fcter OM, S\u00fcdhof TC (2008) A molecular pathway of neurodegeneration linking \u03b1-synuclein to ApoE and A\u03b2 peptides. Nat Neurosci 11:301\u2013308. https:\/\/doi.org\/10.1038\/nn2058","journal-title":"Nat Neurosci"},{"key":"1623_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-8674(03)00509-9","volume":"114","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Lee VMY (2003) Are ubiquitination pathways central to parkinson\u2019s disease? Cell 114:1\u20138. https:\/\/doi.org\/10.1016\/S0092-8674(03)00509-9","journal-title":"Cell"},{"key":"1623_CR16","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JPD-179005","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert M, Jakes R, Spillantini MG (2017) The synucleinopathies: twenty years on. J Parkinsons Dis 7:S51\u2013S69. https:\/\/doi.org\/10.3233\/JPD-179005","journal-title":"J Parkinsons Dis"},{"key":"1623_CR17","doi-asserted-by":"publisher","first-page":"E2634","DOI":"10.1073\/pnas.1713849115","volume":"115","author":"D Grassi","year":"2018","unstructured":"Grassi D, Howard S, Zhou M, Diaz-Perez N, Urban NT, Guerrero-Given D, Kamasawa N, Volpicelli-Daley LA, LoGrasso P, Lasm\u00e9zas CI (2018) Identification of a highly neurotoxic \u03b1-synuclein species inducing mitochondrial damage and mitophagy in Parkinson\u2019s disease. Proc Natl Acad Sci U S A 115:E2634\u2013E2643. https:\/\/doi.org\/10.1073\/pnas.1713849115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1623_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","volume":"17","author":"R Guerreiro","year":"2018","unstructured":"Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(17)30400-3","journal-title":"Lancet Neurol"},{"key":"1623_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-019-1716-z","volume":"575","author":"JA Harris","year":"2019","unstructured":"Harris JA, Mihalas S, Hirokawa KE, Whitesell JD, Choi H, Bernard A, Bohn P, Caldejon S, Casal L, Cho A, Feiner A, Feng D, Gaudreault N, Gerfen CR, Graddis N, Groblewski PA, Henry AM, Ho A, Howard R, Knox JE, Kuan L, Kuang X, Lecoq J, Lesnar P, Li Y, Luviano J, McConoughey S, Mortrud MT, Naeemi M, Ng L, Oh SW, Ouellette B, Shen E, Sorensen SA, Wakeman W, Wang Q, Wang Y, Williford A, Phillips JW, Jones AR, Koch C, Zeng H (2019) Hierarchical organization of cortical and thalamic connectivity. Nature 575:195\u2013202. https:\/\/doi.org\/10.1038\/s41586-019-1716-z","journal-title":"Nature"},{"key":"1623_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s40478-021-01242-2","volume":"9","author":"EW Hass","year":"2021","unstructured":"Hass EW, Sorrentino ZA, Xia Y, Lloyd GM, Trojanowski JQ, Prokop S, Giasson BI (2021) Disease-, region- and cell type specific diversity of \u03b1-synuclein carboxy terminal truncations in synucleinopathies. Acta Neuropathol Commun 9:146. https:\/\/doi.org\/10.1186\/s40478-021-01242-2","journal-title":"Acta Neuropathol Commun"},{"key":"1623_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/archneur.63.2.189","volume":"63","author":"X Huang","year":"2006","unstructured":"Huang X, Chen P, Kaufer DI, Tr\u00f6ster AI, Poole C (2006) Apolipoprotein E and dementia in Parkinson disease: A meta-analysis. Arch Neurol 63:189\u2013193","journal-title":"Arch Neurol"},{"key":"1623_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","volume":"143","author":"Y Jin","year":"2022","unstructured":"Jin Y, Li F, Sonoustoun B, Kondru NC, Martens YA, Qiao W, Heckman MG, Ikezu TC, Li Z, Burgess JD, Amerna D, O\u2019Leary J, DeTure MA, Zhao J, McLean PJ, Dickson DW, Ross OA, Bu G, Zhao N (2022) APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology. Acta Neuropathol 143:641\u2013662. https:\/\/doi.org\/10.1007\/s00401-022-02421-8","journal-title":"Acta Neuropathol"},{"key":"1623_CR23","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1172\/JCI6172","volume":"103","author":"C Knouff","year":"1999","unstructured":"Knouff C, Hinsdale ME, Mezdour H, Altenburg MK, Watanabe M, Quarfordt SH, Sullivan PM, Maeda N (1999) Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J Clin Invest 103:1579\u20131586. https:\/\/doi.org\/10.1172\/JCI6172","journal-title":"J Clin Invest"},{"key":"1623_CR24","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy Bodies: Dissimilar Incorporation of \u03b1-Synuclein, Ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241\u20131253. https:\/\/doi.org\/10.1093\/jnen\/62.12.1241","journal-title":"J Neuropathol Exp Neurol"},{"key":"1623_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41531-022-00388-7","volume":"8","author":"HA Lashuel","year":"2022","unstructured":"Lashuel HA, Mahul-Mellier A-L, Novello S, Hegde RN, Jasiqi Y, Altay MF, Donzelli S, DeGuire SM, Burai R, Magalh\u00e3es P, Chiki A, Ricci J, Boussouf M, Sadek A, Stoops E, Iseli C, Guex N (2022) Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity. npj Park Dis 8:136. https:\/\/doi.org\/10.1038\/s41531-022-00388-7","journal-title":"npj Park Dis"},{"key":"1623_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature05453","volume":"445","author":"ES Lein","year":"2007","unstructured":"Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L, Chen L, Chen TM, Chin MC, Chong J, Crook BE, Czaplinska A, Dang CN, Datta S, Dee NR, Desaki AL, Desta T, Diep E, Dolbeare TA, Donelan MJ, Dong HW, Dougherty JG, Duncan BJ, Ebbert AJ, Eichele G, Estin LK, Faber C, Facer BA, Fields R, Fischer SR, Fliss TP, Frensley C, Gates SN, Glattfelder KJ, Halverson KR, Hart MR, Hohmann JG, Howell MP, Jeung DP, Johnson RA, Karr PT, Kawal R, Kidney JM, Knapik RH, Kuan CL, Lake JH, Laramee AR, Larsen KD, Lau C, Lemon TA, Liang AJ, Liu Y, Luong LT, Michaels J, Morgan JJ, Morgan RJ, Mortrud MT, Mosqueda NF, Ng LL, Ng R, Orta GJ, Overly CC, Pak TH, Parry SE, Pathak SD, Pearson OC, Puchalski RB, Riley ZL, Rockett HR, Rowland SA, Royall JJ, Ruiz MJ, Sarno NR, Schaffnit K, Shapovalova NV, Sivisay T, Slaughterbeck CR, Smith SC, Smith KA, Smith BI, Sodt AJ, Stewart NN, Stumpf KR, Sunkin SM, Sutram M, Tam A, Teemer CD, Thaller C, Thompson CL, Varnam LR, Visel A, Whitlock RM, Wohnoutka PE, Wolkey CK, Wong VY, Wood M, Yaylaoglu MB, Young RC, Youngstrom BL, Yuan XF, Zhang B, Zwingman TA, Jones AR (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168\u2013176. https:\/\/doi.org\/10.1038\/nature05453","journal-title":"Nature"},{"key":"1623_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41380-021-01233-8","volume":"27","author":"B Liu","year":"2022","unstructured":"Liu B, Ruan J, Chen M, Li Z, Manjengwa G, Schl\u00fcter D, Song W, Wang X (2022) Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases. Mol Psychiatry 27:259\u2013268. https:\/\/doi.org\/10.1038\/s41380-021-01233-8","journal-title":"Mol Psychiatry"},{"key":"1623_CR28","doi-asserted-by":"publisher","first-page":"22670","DOI":"10.1074\/jbc.M501508200","volume":"280","author":"CW Liu","year":"2005","unstructured":"Liu CW, Giasson BI, Lewis KA, Lee VM, DeMartino GN, Thomas PJ (2005) A precipitating role for truncated \u03b1-synuclein and the proteasome in \u03b1-synuclein aggregation: Implications for pathogenesis of parkinson disease. J Biol Chem 280:22670\u201322678. https:\/\/doi.org\/10.1074\/jbc.M501508200","journal-title":"J Biol Chem"},{"key":"1623_CR29","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00401-022-02425-4","volume":"143","author":"GM Lloyd","year":"2022","unstructured":"Lloyd GM, Sorrentino ZA, Quintin S, Gorion K-MM, Bell BM, Paterno G, Long B, Prokop S, Giasson BI (2022) Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human \u03b1-synuclein transgenic mice. Acta Neuropathol 143:663\u2013685. https:\/\/doi.org\/10.1007\/s00401-022-02425-4","journal-title":"Acta Neuropathol"},{"key":"1623_CR30","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","volume":"71","author":"IF Mata","year":"2014","unstructured":"Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, Revilla FJ, Devoto J, Hu SC, Cholerton BA, Wan JY, Montine TJ, Edwards KL, Zabetian CP (2014) APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol 71:1405\u20131412. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1455","journal-title":"JAMA Neurol"},{"key":"1623_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"1623_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/bi0485528","volume":"44","author":"T Nonaka","year":"2005","unstructured":"Nonaka T, Iwatsubo T, Hasegawa M (2005) Ubiquitination of \u03b1-synuclein. Biochemistry 44:361\u2013368. https:\/\/doi.org\/10.1021\/bi0485528","journal-title":"Biochemistry"},{"key":"1623_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature13186","volume":"508","author":"SW Oh","year":"2014","unstructured":"Oh SW, Harris JA, Ng L, Winslow B, Cain N, Mihalas S, Wang Q, Lau C, Kuan L, Henry AM, Mortrud MT, Ouellette B, Nguyen TN, Sorensen SA, Slaughterbeck CR, Wakeman W, Li Y, Feng D, Ho A, Nicholas E, Hirokawa KE, Bohn P, Joines KM, Peng H, Hawrylycz MJ, Phillips JW, Hohmann JG, Wohnoutka P, Gerfen CR, Koch C, Bernard A, Dang C, Jones AR, Zeng H (2014) A mesoscale connectome of the mouse brain. Nature 508:207\u2013214. https:\/\/doi.org\/10.1038\/nature13186","journal-title":"Nature"},{"key":"1623_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41531-022-00411-x","volume":"8","author":"NU Okubadejo","year":"2022","unstructured":"Okubadejo NU, Okunoye O, Ojo OO, Arabambi B, Akinyemi RO, Osaigbovo GO, Abubakar SA, Iwuozo EU, Wahab KW, Agabi OP, Agulanna U, Imarhiagbe FA, Abiodun OV, Achoru CO, Adebowale AA, Adeniji O, Akpekpe JE, Ali MW, Ani-Osheku I, Arigbodi O, Balarabe SA, Bello AH, Ekenze OS, Erameh CO, Farombi TH, Fawale MB, Komolafe MA, Nwani PO, Nwazor EO, Nyandaiti Y, Obehighe EE, Obiabo YO, Odeniyi OA, Odiase FE, Ojini FI, Onwuegbuzie GA, Osemwegie N, Oshinaike OO, Otubogun FM, Oyakhire SI, Taiwo FT, Williams UE, Ozomma S, Zubair Y, Hernandez D, Bandres-Ciga S, Blauwendraat C, Singleton A, Houlden H, Hardy J, Rizig M (2022) APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson\u2019s disease. npj Park Dis 8:155. https:\/\/doi.org\/10.1038\/s41531-022-00411-x","journal-title":"npj Park Dis"},{"key":"1623_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29419","author":"TF Outeiro","year":"2023","unstructured":"Outeiro TF, Alcalay RN, Antonini A, Attems J, Bonifati V, Cardoso F, Chesselet M-F, Hardy J, Madeo G, McKeith I, Mollenhauer B, Moore DJ, Rascol O, Schlossmacher MG, Soreq H, Stefanis L, Ferreira JJ (2023) Defining the riddle in order to solve it: there is more than one \u201cParkinson\u2019s disease.\u201d Mov Disord Epub ahead. https:\/\/doi.org\/10.1002\/mds.29419","journal-title":"Mov Disord Epub ahead"},{"key":"1623_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5. https:\/\/doi.org\/10.1186\/s13024-019-0306-8","journal-title":"Mol Neurodegener"},{"key":"1623_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JPD-150762","volume":"6","author":"KC Paul","year":"2016","unstructured":"Paul KC, Rausch R, Creek MM, Sinsheimer JS, Bronstein JM, Bordelon Y, Ritz B (2016) APOE, MAPT, and COMT and Parkinson\u2019s disease susceptibility and cognitive symptom progression. J Parkinsons Dis 6:349\u2013359. https:\/\/doi.org\/10.3233\/JPD-150762","journal-title":"J Parkinsons Dis"},{"key":"1623_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/ajmg.10111","volume":"107","author":"H Payami","year":"2002","unstructured":"Payami H, Nutt J, Kaye J, Bird T, Camicioli R, Zareparsi S, Sexton G, Swanson P (2002) Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet 107:156\u2013161. https:\/\/doi.org\/10.1002\/ajmg.10111","journal-title":"Am J Med Genet"},{"key":"1623_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mds.28805","volume":"37","author":"JL Pu","year":"2022","unstructured":"Pu JL, Jin CY, Wang ZX, Fang Y, Li YL, Xue NJ, Zheng R, Lin ZH, Yan YQ, Si XL, Chen Y, Liu Y, Song Z, Yan YP, Tian J, Yin XZ, Zhang BR (2022) Apolipoprotein E genotype contributes to motor progression in Parkinson\u2019s disease. Mov Disord 37:196\u2013200. https:\/\/doi.org\/10.1002\/mds.28805","journal-title":"Mov Disord"},{"key":"1623_CR40","doi-asserted-by":"publisher","first-page":"104912","DOI":"10.1016\/j.jbc.2023.104912","volume":"299","author":"S Quintin","year":"2023","unstructured":"Quintin S, Lloyd GM, Paterno G, Xia Y, Sorrentino Z, Bell BM, Gorion K-M, Lee EB, Prokop S, Giasson BI (2023) Cellular processing of \u03b1-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114. J Biol Chem 299:104912. https:\/\/doi.org\/10.1016\/j.jbc.2023.104912","journal-title":"J Biol Chem"},{"key":"1623_CR41","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1038\/s41598-019-43458-2","volume":"9","author":"A Rongve","year":"2019","unstructured":"Rongve A, Witoelar A, Ruiz A, Athanasiu L, Abdelnour C, Clarimon J, Heilmann-Heimbach S, Hern\u00e1ndez I, Moreno-Grau S, de Rojas I, Morenas-Rodr\u00edguez E, Fladby T, Sando SB, Br\u00e5then G, Blanc F, Bousiges O, Lemstra AW, van Steenoven I, Londos E, Almdahl IS, P\u00e5lhaugen L, Eriksen JA, Djurovic S, Stordal E, Saltvedt I, Ulstein ID, Bettella F, Desikan RS, Idland AV, Toft M, Pihlstr\u00f8m L, Snaedal J, T\u00e1rraga L, Boada M, Lle\u00f3 A, Stef\u00e1nsson H, Stef\u00e1nsson K, Ram\u00edrez A, Aarsland D, Andreassen OA (2019) GBA and APOE \u03b54 associate with sporadic dementia with Lewy bodies in European genome wide association study. Sci Rep 9:7013. https:\/\/doi.org\/10.1038\/s41598-019-43458-2","journal-title":"Sci Rep"},{"key":"1623_CR42","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.1321785111","volume":"111","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW, McGarvey NH, Ayers JI, Notterpek L, Borchelt DR, Golde TE, Giasson BI (2014) Intramuscular injection of -synuclein induces CNS -synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci 111:10732\u201310737. https:\/\/doi.org\/10.1073\/pnas.1321785111","journal-title":"Proc Natl Acad Sci"},{"key":"1623_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-017-0182-z","volume":"12","author":"ZA Sorrentino","year":"2017","unstructured":"Sorrentino ZA, Brooks MMT, Hudson V, Rutherford NJ, Golde TE, Giasson BI, Chakrabarty P (2017) Intrastriatal injection of \u03b1-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity. Mol Neurodegener 12:40. https:\/\/doi.org\/10.1186\/s13024-017-0182-z","journal-title":"Mol Neurodegener"},{"key":"1623_CR44","doi-asserted-by":"publisher","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","volume":"295","author":"ZA Sorrentino","year":"2020","unstructured":"Sorrentino ZA, Giasson BI (2020) The emerging role of \u03b1-synuclein truncation in aggregation and disease. J Biol Chem 295:10224\u201310244. https:\/\/doi.org\/10.1074\/jbc.REV120.011743","journal-title":"J Biol Chem"},{"key":"1623_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2018.09.005","volume":"120","author":"ZA Sorrentino","year":"2018","unstructured":"Sorrentino ZA, Xia Y, Funk C, Riffe CJ, Rutherford NJ, Ceballos Diaz C, Sacino AN, Price ND, Golde TE, Giasson BI, Chakrabarty P (2018) Motor neuron loss and neuroinflammation in a model of \u03b1-synuclein-induced neurodegeneration. Neurobiol Dis 120:98\u2013106. https:\/\/doi.org\/10.1016\/j.nbd.2018.09.005","journal-title":"Neurobiol Dis"},{"key":"1623_CR46","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","volume":"272","author":"PM Sullivan","year":"1997","unstructured":"Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272:17972\u201317980. https:\/\/doi.org\/10.1074\/jbc.272.29.17972","journal-title":"J Biol Chem"},{"key":"1623_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1172\/JCI2673","volume":"102","author":"PM Sullivan","year":"1998","unstructured":"Sullivan PM, Mezdour H, Quarfordt SH, Maeda N (1998) Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human APOE*2. J Clin Invest 102:130\u2013135. https:\/\/doi.org\/10.1172\/JCI2673","journal-title":"J Clin Invest"},{"key":"1623_CR48","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.28932","volume":"37","author":"AA Szwedo","year":"2022","unstructured":"Szwedo AA, Dalen I, Pedersen KF, Camacho M, B\u00e4ckstr\u00f6m D, Forsgren L, Tzoulis C, Winder-Rhodes S, Hudson G, Liu G, Scherzer CR, Lawson RA, Yarnall AJ, Williams-Gray CH, Macleod AD, Counsell CE, Tysnes OB, Alves G, Maple-Gr\u00f8dem J (2022) GBA and APOE Impact cognitive decline in Parkinson\u2019s disease: a 10-year population-based study. Mov Disord 37:1016\u20131027. https:\/\/doi.org\/10.1002\/mds.28932","journal-title":"Mov Disord"},{"key":"1623_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP (2013) APOE \u03b54 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70:223\u2013228. https:\/\/doi.org\/10.1001\/jamaneurol.2013.600","journal-title":"JAMA Neurol"},{"key":"1623_CR50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/NEN.0b013e31816fc995","volume":"67","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Giasson BI (2008) Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J Neuropathol Exp Neurol 67:402\u2013416. https:\/\/doi.org\/10.1097\/NEN.0b013e31816fc995","journal-title":"J Neuropathol Exp Neurol"},{"key":"1623_CR51","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ajpath.2011.07.021","volume":"179","author":"MMM Wilhelmus","year":"2011","unstructured":"Wilhelmus MMM, Bol JGJM, Van Haastert ES, Rozemuller AJM, Bu G, Drukarch B, Hoozemans JJM (2011) Apolipoprotein e and LRP1 increase early in Parkinson\u2019s disease pathogenesis. Am J Pathol 179:2152\u20132156. https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.021","journal-title":"Am J Pathol"},{"key":"1623_CR52","doi-asserted-by":"publisher","first-page":"eaay1809","DOI":"10.1126\/scitranslmed.aay1809","volume":"12","author":"N Zhao","year":"2020","unstructured":"Zhao N, Attrebi ON, Ren Y, Qiao W, Sonustun B, Martens YA, Meneses AD, Li F, Shue F, Zheng J, Van Ingelgom AJ, Davis MD, Kurti A, Knight JA, Linares C, Chen Y, Delenclos M, Liu C-C, Fryer JD, Asmann YW, McLean PJ, Dickson DW, Ross OA, Bu G (2020) APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid. Sci Transl Med 12:eaay1809. https:\/\/doi.org\/10.1126\/scitranslmed.aay1809","journal-title":"Sci Transl Med"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01623-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01623-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01623-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T06:01:17Z","timestamp":1690092077000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01623-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01623-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,23]]},"assertion":[{"value":"31 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed according to the National Institute of Health Guide for the Care and Use of Experimental Animals and were approved by the University of Florida Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We declare no competing interest in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}